Latest Governance News

Aspermont Limited's trading suspension has been lifted following a key announcement about new board appointments, signaling a fresh chapter for the media publisher.

Aspermont Limited has appointed John Stark and David Straface as interim directors, reinforcing its board with seasoned insiders during a pivotal growth phase focused on data and intelligence services for global resource sectors.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Stealth Group Holdings has explained the late filing of a director’s interest notice as an administrative oversight, assuring no market harm occurred. The company has since strengthened its compliance controls to prevent future lapses.

Askari Metals Limited’s AS2OC securities have been suspended from trading pending compliance with ASX Listing Rule 2.5, raising questions about the company’s regulatory standing.

Group One Capital Limited has adopted a comprehensive replacement Constitution at its 2025 Annual General Meeting, setting a refreshed governance framework aligned with current regulatory standards.

Qube Holdings reported a robust FY25 with significant revenue and earnings growth, strategic acquisitions, and a refreshed board leadership. Despite operational challenges, the company raised its dividend and confirmed solid FY26 earnings guidance.

Sonic Healthcare has reaffirmed its FY2026 EBITDA guidance with up to 13% growth, reported solid FY2025 financial results, and announced a strategic acquisition in Germany alongside notable sustainability progress.

CVC Limited has released a replacement prospectus for its $75 million CVC Notes 3 offer, combining a New Money Offer and a Reinvestment Offer for existing CVCHA holders. The notes aim to support CVC’s capital management and real estate investment strategy.

Hansen Technologies reported robust FY25 results driven by double-digit revenue growth, strategic contract wins, and a transformative acquisition of UK-based Digitalk. The company’s integration of AI and sustainability initiatives underpin a confident outlook for sustained growth.